Common Stock, $0.001 par value per share
- Symbol
- HTFL
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
HTFLNASDAQEQUITYCurrent
Item 2.02 Results of Operations and Financial Condition . On May 14, 2026, Heartflow, Inc. issued a press release regarding its financial results for the quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Heartflow’s technology is redefining precision diagnostic testing and management for coronary artery disease (CAD) through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,800 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 625 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 800,000 patients worldwide. 1 Key benefits include:
Heartflow, Inc. · 8-K · Filed 2026-05-14
EX-99.1 2 htfl-20260514xex99_1.htm EX-99.1 Exhibit 99.1 2026.05.14 Exhibit 99.1 Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance SAN FRANCISCO - May 14, 2026 - Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Total revenue of $52.6 million, a 41% increase year-over-year Gross margin of 80.2%, non-GAAP gross margin of 80.5% Net operating loss of $29.5 million, including a $7.5 million non-cash impairment charge associated with facilities optimization and headquarters relocation to San Francisco. Non-GAAP net operating loss was $15.5 million 2026 Annual Guidance Total revenue of $228 million to $232 million (approximately 29% to 32% growth year-over-year), compared to previous guidance of $218 million to $222 million (approximately 24% to 26% growth year-over-year) Non-GAAP gross margin of approximately 81%, compared to previous guidance of 80% to 81% “Heartflow entered 2026 with unprecedented momentum, expanding the category leadership we establis…
Open exhibit ↗